Live
- RBI inks pact to link UPI with 4 ASEAN countries for instant cross-border retail payments
- Pawan Kalyan was saddened by the financial crisis of the AP
- Recruitment of 77,305 done without irregularities, says Maha Dy CM
- Honoring Compassionate Care: National Doctor’s Day 2024
- Use of AI for self-prescription poses risk to human life, warn doctors
- Telangana HC dismisses KCR’s petition against Judicial Commission
- Royal Challengers Bengaluru (RCB) appoint Dinesh Karthik as batting coach, mentor
- New criminal laws: First FIR filed in Delhi’s Seelampur, second in Kamla market
- India to be part of citizen astronaut programme by SERA, Blue Origin
- 17-year-old Chinese badminton player collapses on court, passes away
DCA seizes mislabeled drugs
Hyderabad: The Telangana State Drug Control Administration (DCA) seized spurious drugs falsely claimed to be manufactured by Abbott India...
Hyderabad: The Telangana State Drug Control Administration (DCA) seized spurious drugs falsely claimed to be manufactured by Abbott India Limited.
According to DCA, the officers conducted raids at Goel Pharma, Sultan Bazaar, Koti and Yashwanth Pharma, Moosarambagh in Hyderabad and seized counterfeit versions of Vertin 8 (Betahistine tablets) and Vertin 16 tablets, which are prescribed by doctors to treat symptoms of Meniere’s Disease, which includes vertigo (feeling dizzy and spinning sensation), tinnitus (ringing in ears), hearing loss and nausea.
During the raids on Thursday and Friday, large stocks of both the drugs were seized and a comparison statement obtained for the suspected batches from the original manufacturer. The manufacturer also concluded that the batches ‘Vertin 8’ tablets and ‘Vertin 16’ tablets were spurious/ counterfeit drugs.
In another raid, the stocks of overpriced Itragril-200 capsules, which are anti-fungal in nature and fall under price control as per Drugs (Prices Control) Order, 2013 set by NPPA, were also seized from a medical shop in Shivunipally village, Station Ghanpur, Jangaon district.
The seized stocks of Intragril-200 capsules were being retailed at Rs 289.50 for 10 capsules, which is the MRP in the product label with each capsule costing roughly Rs 29. However, the NPPA ceiling price for a single capsule of this drug is Rs 24.77 (including GST).
According to DCA, the firm charged an excess of Rs 41.80 for 10 capsules, which is a violation of Drugs (Price Control Order, 2013).
The TSDCA said that they have also detected and seized certain medicines circulating in the market with misleading claims, stating that they treat kidney stones, kidney stones and piles. The seized products include Ayurveda medicine Blastone Syrup (manufactured by Balu Herbals, Rangareddy district) with misleading claim of treating kidney stones, Carivent Tablets (Onika Organics, Karnal) and Allopathic medicine Hadensa Ointment for pile, manufactured by Dollar Company, Tondiarpet, Chennai.
